One-year follow-up data from Phase 2 trial of once-weekly canvuparatide, a potential best-in-class therapy for ...
If you ever find a personal or work task daunting, you might just need to rethink how you approach it. Pomodoro apps and ...
Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 million, to support Teva’s anti-IL-15 candidate, TEV-‘408 ...
Real-time index price for Nasdaq Computer Index (IXCO), along with buy or sell indicators, analysis, charts, historical performance, news and more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results